Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study

Creative Commons License

Bayoglu I. V., Yildiz I., Varol U., Cokmert S., Alacacioglu A., Kucukzeybek Y., ...More

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, vol.19, pp.385-390, 2015 (ESCI) identifier identifier identifier


Aim of the study: Our aim was to determine the activity and toxicity of uracil/tegafur and leucovorin combination in metastatic colorectal cancer (mCRC) patients who have progressed with all currently active agents.